Articles about Visit

The Charlotte Hornets face the San Antonio Spurs at 3:30 p.m. ET in an NBA regular-season game streamed on Prime Video. This matchup features contrasting team strategies amid playoff positioning efforts. It kicks off a full slate including Wizards-Celtics and Nuggets-Lakers later Saturday. NBA action highlights key Western Conference battles.

Denver Nuggets face the Los Angeles Lakers at 8:30 p.m. ET on ABC, pitting Nikola Jokic against LeBron James in a Western Conference showdown. Jokic leads the Nuggets with 27.8 points, 13.2 rebounds, and 9.1 assists per game this season. Lakers seek revenge after a 112-105 loss in January. Winner gains crucial tiebreaker edge with 20 games left in regular season.

Traditionally jovial affair poses potential debacle for Irish leader at odds with US over foreign policy, tax and immigrationFor Ireland’s leaders, it has long been the highlight of the political calendar: a love-fest in Washington with hosts who sport shamrocks and toast Saint Patrick.Irish delegations are traditionally received on Capitol Hill and at the White House in a blaze of goodwill and backslapping that has them wishing every day was 17 March. Continue reading...

CDC interim analysis from September 2025 to February 2026 shows this season's flu vaccine effectiveness at 22-34% against outpatient visits for adults and 30-41% for those 65+, with hospitalization protection at 30-31%, due to H3N2 strain mismatch. The season saw 27 million illnesses, 350,000 hospitalizations, and 22,000 deaths, lower than last year's peaks but with 101 child deaths, 85% unvaccinated. Despite flaws, experts like Dr. William Schaffner stress shots prevent severe outcomes, with adult rates at 46.5%. Vaccination campaigns will target improved strains for next season.

CDC studies from September 2025 to February 2026 estimate flu vaccine effectiveness (VE) at 22-34% against influenza A/B outpatient visits for adults and 30-41% for those 65+, with 30-31% against hospitalizations. Patrick Maloney, PhD, from CDC's National Center for Immunization and Respiratory Diseases, led the analysis. Low VE underscores need for improved formulations amid slumping protection. Findings inform next season's vaccine development.